Register
Login:
Share:
Email Facebook Twitter


Share Views Episode 4: Mid & Large Caps with Chris Bailey


Sareum Share Chat (SAR)



Share Price: 0.775Bid: 0.75Ask: 0.80Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.05Spread as %: 6.67%Open: 0.74High: 0.775Low: 0.74Yesterday’s Close: 0.775


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


seaniebb
Posts: 647
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.775
RE: link
Thu 18:57
Thanks for confirming very kind.
 
zylo
Posts: 4,237
Off Topic
Opinion:No Opinion
Price:0.775
sean
Thu 18:55
That molecule is for chk2

Developed by ICR -nothing to do with us
seaniebb
Posts: 647
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.775
RE: Link...
Thu 18:18
Jon

I notice that the great link which you found contains a compound CCT241533 which is under pre clinical development. Is this an older version of our trial compound do you know or is it a separate compound not related to SAR?

Sorry to be a pain.
MePension
Posts: 222
Off Topic
Opinion:No Opinion
Price:0.775
View Thread (2)
RE: Me pension
Thu 18:11
Many thanks Egatrom.
I was fortunate to make some nice money back in 2010-11 on the last spike, but this is ready to outshine that, by a long way.
If i do miss it their is always other companies i am still in a few.
You never know if a few clients pay their bills i,ll be back.
Egatrom
Posts: 88
Off Topic
Opinion:Strong Buy
Price:0.775
RE: Me pension
Thu 18:02
Hope your cashflow improves so you can get back in, even if we get a spike there will be times I'm sure that will give you an entry point, Good luck to you.
Egatrom
Posts: 88
Off Topic
Opinion:Strong Buy
Price:0.775
View Thread (2)
RE: Me pension
Thu 17:59
I agree Thoth2, it can't just be a coincidence that AZN have sniffed around SAR B4 and now with Chk1 trials, the stamp of approval from CRUK, that they now say they are going to concentrate on oncology. Not a big leap of faith that they may have eyes for SAR. If they have it will be kept very much under wraps until they are all good and ready.
MePension
Posts: 222
Off Topic
Opinion:No Opinion
Price:0.775
RE: Me pension
Thu 17:55
Many thanks Thoth2.
I am hoping to be back in sometime next month, just hope news is delayed for a while.

So....Tim if your listening, can you wait a bit longer before releasing any news until i can get back in, i will let you when.
JonBell
Posts: 263
Off Topic
Opinion:Strong Buy
Price:0.775
RE: Link...
Thu 17:47
Great find Jon, much appreciated.
Still no negative news to be found on any of our compounds. Hold tight.
Love, peace and harmony.
Thoth2
Posts: 893
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.775
View Thread (4)
Me pension
Thu 17:14
sorry about the cashflow- happens to all of us sometimes.
Tim flagged "newsflow " on the presentation I posted earlier saying the would be an update on auroara & on Tyk2 in Q2/3. So yes Im expecting something.
as a teaser, AZN sold its antibiotics unit for $550m upfront to focus on oncology...
Speculation of course but we know that they have been looking for a Chk1 compound as a combo with their wee1 inhibitor.
http://www.fiercebiotech.com/biotech/it-didn-t-get-whole-package-but-pfizer-will-pay-1-5b-for-az-s-antibiotics-biz




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.